Get up to speed with the latest psychedelic developments. Short daily – more personal – articles on psychedelics, from industry news to psychedelic research.

Journey to the druidic lands of Exeter for a gathering of science and spirituality. Join me in revisiting Breaking Convention 2023.
PAREA organised a meeting in the European Parliament on psychedelic-assisted therapies for the treatment of mental health issues.
212 people that have gone through psychedelic trials for which we have data that extends beyond 3 months. We need more data if we want psychedelic-assisted therapy (PAT) to scale.
The take home messages from the Interdisciplinary Conference on Psychedelic Research 2022. Novel results, DMT, and a personal note.
Researchers associated with Mindbloom just published an article arguing that at-home ketamine-assisted therapy is not only safe but led to improvements (<50%) in depression and anxiety in 62% of participants.
Psychedelic therapy is going mainstream - it won’t be long before these therapies are rolled out in clinics across the globe once the regulations around these substances are changed.
Health systems are unprepared to offer and meet the demand for psychedelic-assisted therapy - we can start to prepare now.
The legal issues and stigma surrounding psychedelics have deterred many traditional sources from funding - now, things are changing.
The next generation of psychedelics is already here – let's take a look at the advantages and disadvantages.
Despite psychedelics remaining highly controlled – it hasn’t deterred investors and a sizeable market has developed.

Blossom’s Bits

We examine what is happening in the psychedelic landscape and make this accessible in short daily articles. Some articles put the news into context, others excerpt our long-form reports to make a key insight visible. At other times, the bits serve as a place to share an interview, viewpoint, or experience. All to keep you in the loop on what’s happening in psychedelics as medicine.